CNIO - Spanish National Cancer Research Centre
Javier Coloma is a seasoned scientist currently serving as a Staff Scientist at the CNIO - Spanish National Cancer Research Centre since December 2017. Prior experience includes positions as a Staff Scientist at the New York Structural Biology Center from November 2016 to August 2017, and as a Postdoctoral Research Fellow at Mount Sinai School of Medicine from November 2010 to October 2016, where research focused on structural studies of druggable targets related to DNA replication, particularly determining the structure of human DNA Polα in complex with a DNA:DNA double helix. Earlier work at CNIO from September 2004 to August 2010 as a Predoctoral Fellow involved the structural analysis of protein complexes engaged in DNA interactions, resulting in the 3D reconstruction of the human GINS complex. Javier Coloma's academic background includes a Licenciatura in Biochemistry from Universidad Autónoma de Madrid and an Erasmus grant in Biochemistry, Biophysics, and Molecular Biology from the University of Leeds.
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.